sever
acut
respiratori
syndrom
coronaviru
sarscov
like
transmit
bat
respons
worldwid
sarsoutbreak
coronavirus
belong
order
nidoviral
character
largest
positivestrand
rna
rna
genom
around
nt
known
viru
world
enzymolog
rna
synthesi
therefor
thought
significantli
complex
rna
viru
group
twothird
cov
genom
open
read
frame
translat
viral
replicas
polyprotein
figur
give
rise
nonstructur
protein
nsp
co
posttransl
autoproteolyt
process
third
encod
viral
structur
protein
sever
socal
accessori
protein
express
set
four
nine
subgenom
sg
mrna
latter
transcrib
subgenomelength
minusstrand
templat
whose
product
involv
uniqu
mechan
discontinu
rna
synthesi
review
organ
complex
rna
synthesi
genom
express
cov
proteom
includ
sever
enzym
activ
rare
lack
rna
viru
famili
review
year
follow
sar
outbreak
bioinformat
structur
biolog
revers
genet
biochem
studi
contribut
indepth
character
cov
nsp
gener
sarscov
particular
current
document
enzym
activ
includ
two
proteinas
put
rna
primas
rnadepend
rna
polymeras
helicaserna
triphosphatas
exo
endoribonucleas
sadenosyllmethionin
adomet
depend
methyltransferas
propos
play
role
format
cov
mrna
cap
base
compar
sequenc
analysi
presum
encod
adometdepend
mrna
cap
methyltransferas
sarscov
howev
enzym
activ
remain
elus
thu
far
experiment
evid
exist
obtain
relat
felin
coronaviru
fcov
cov
nsp
form
viral
replicationtranscript
complex
rtc
thought
local
network
endoplasm
reticulumderiv
modifi
membran
infect
cell
proteinprotein
interact
propos
essenti
assembl
rtc
may
therefor
also
regul
activ
enzym
involv
viral
rna
synthesi
although
end
sarscov
mrna
character
yet
assum
carri
cap
structur
assumpt
base
characteris
genom
subgenom
mrna
coronaviru
murin
hepat
viru
mhv
relat
equin
toroviru
etov
bern
viru
also
belong
coronavirida
famili
mrna
virus
conclud
carri
cap
structur
moreov
coronaviru
toroviru
genom
three
enzym
put
involv
mrna
cap
identifi
although
remain
poorli
characteris
cap
structur
promot
initi
translat
protect
mrna
exoribonucleas
activ
synthesi
cap
structur
eukaryot
involv
three
sequenti
enzymat
activ
rna
triphosphatas
rtpase
remov
group
mrna
ii
guanylyltransferas
gtase
catalyz
transfer
gmp
remain
terminu
iii
methyl
cap
guanin
thu
produc
socal
structur
wherea
lower
eukaryot
includ
yeast
employ
structur
higher
eukaryot
convert
structur
mean
methyl
ribos
first
second
nucleotid
mrna
respect
rna
cap
methyl
essenti
sinc
prevent
pyrophosphorolyt
revers
guanylyltransf
reaction
ensur
effici
bind
ribosom
case
rna
virus
alphavirus
flavivirus
mutat
rna
cap
methyl
gene
shown
lethal
detriment
viru
replic
coronavirus
function
genet
analysi
perform
mhv
temperatur
sensit
mutant
map
domain
cov
indic
involv
positivestrand
rna
synthesi
previous
form
replicasetranscriptas
complex
import
viral
rna
synthesi
support
data
obtain
mutagenesi
mtase
catalyt
residu
sarscov
rna
replicon
system
case
coronavirus
machineri
put
involv
equip
genom
subgenom
mrna
structur
thought
consist
multifunct
may
contribut
rtpase
activ
helicas
domain
ii
still
unknown
gtase
iii
ctermin
domain
recent
identifi
iv
put
use
mammalian
yeast
twohybrid
system
well
pulldown
assay
shown
sarscov
specif
interact
suggest
may
play
role
viral
cap
pathway
crystal
structur
small
rnabind
protein
contain
two
zinc
finger
recent
solv
role
mode
action
viral
replic
cycl
remain
elus
view
phenotyp
mous
hepat
viru
mhv
mutant
role
viral
rna
synthesi
postul
studi
implic
replicas
polyprotein
process
sarscov
also
shown
bind
singl
doublestrand
rna
dna
low
affin
without
obviou
sequenc
specif
studi
report
discoveri
function
sarscov
essenti
factor
trigger
full
activ
deciph
rna
cap
methyl
sequenc
necessarili
preced
pair
sarscov
trio
constitut
attract
target
packag
antivir
drug
discoveri
design
inde
seem
play
import
role
viral
replic
accordingli
set
sensit
inhibit
test
activ
valid
low
valu
known
adometdepend
mtase
inhibitor
moreov
show
aurintricarboxyl
acid
ata
shown
inhibit
sarscov
replic
target
mtase
inde
unlik
flavivirus
use
singl
activ
site
protein
activ
coronavirus
presum
encod
two
separ
mtase
catalyz
last
two
step
format
methyl
rnacap
structur
sarscov
shown
rnacap
sequenc
motif
canon
identifi
experiment
verif
mtase
activ
report
contrast
fcov
rather
low
activ
could
demonstr
sarscov
previous
shown
interact
suggest
involv
rna
cap
andor
methyl
consequ
clone
express
e
coli
purifi
recombin
protein
use
ntermin
metal
affin
chromatographi
express
fusion
protein
intein
tag
cterminu
product
bound
chitin
affin
column
untag
protein
elut
remov
tag
dtt
treatment
three
protein
purifi
size
exclus
chromatographi
upon
sdspage
purifi
protein
migrat
singl
band
correspond
expect
molecular
mass
kda
kda
kda
figur
ident
recombin
protein
confirm
trypsin
digest
mass
spectrometri
malditof
data
shown
use
purifi
recombin
protein
first
conduct
vitro
mtase
assay
short
cap
rna
substrat
methyl
guanin
cap
use
possibl
combin
three
protein
incub
substrat
presenc
tritiat
methyl
donor
adomet
extent
transfer
quantifi
reaction
time
min
use
deae
filterbind
assay
see
materi
method
figur
show
methyl
timedepend
manner
wherea
neither
alon
appar
activ
bare
influenc
presenc
addit
observ
methyl
figur
suggest
methyl
cap
structur
contrast
catalyz
methyltransf
neither
reaction
condit
surprisingli
activ
assay
supplement
robust
methyl
observ
figur
figur
control
reaction
contain
either
alon
supplement
mtase
activ
detect
figur
substrat
incub
combin
figur
level
substrat
methyl
enhanc
compar
reaction
perform
alon
overnight
incub
three
protein
methyl
incorpor
reach
plateau
incorpor
level
twice
higher
reaction
presenc
alon
shown
contrast
signific
differ
observ
methyl
level
reach
incub
substrat
either
three
protein
pair
figur
taken
togeth
result
suggest
sarscov
methyl
cap
guanin
inde
act
substrat
ii
act
iii
activ
requir
presenc
cap
structur
alreadi
methyl
iv
pair
perform
sequenti
doubl
methyl
presum
determin
stimul
mtase
activ
coexpress
e
coli
ntermin
streptag
bacteri
cell
lysat
contain
protein
incub
streptactin
bead
see
materi
method
order
bind
tag
extens
wash
protein
bound
bead
analys
use
sdspage
figur
indic
remain
associ
wherea
alon
unabl
bind
bead
data
suggest
stimul
mtase
activ
direct
associ
result
format
complex
intens
band
correspond
quantifi
ratio
obtain
correct
respect
molecular
mass
assum
bind
coomassi
blue
dye
affin
yield
ratio
suggest
complex
contain
larg
molar
excess
one
might
expect
due
fact
seem
form
dodecam
certain
condit
order
test
mtase
activ
virusspecif
cap
rna
substrat
synthes
rna
correspond
first
nucleotid
sarscov
genom
use
rna
polymeras
sinc
canon
promot
ineffici
direct
transcript
rna
begin
requir
make
transcript
resembl
end
coronaviru
rna
use
class
ii
promot
addit
introduc
substitut
posit
rna
increas
vitro
transcript
effici
data
shown
rna
cap
gtp
use
vaccinia
viru
vv
cap
enzym
contain
rtpase
gtase
activ
see
materi
method
presenc
absenc
methyl
donor
adomet
substrat
incub
variou
combin
reaction
product
digest
nucleas
order
releas
rna
cap
structur
radiolabel
cap
molecul
subsequ
separ
tlc
plate
visual
use
autoradiographi
comparison
commerci
avail
inhous
synthes
cap
analog
allow
identif
methyl
posit
cap
structur
figur
show
cap
structur
releas
nucleas
digest
substrat
rna
comigr
expect
gpppa
cap
analog
respect
presenc
vv
posit
control
gpppa
cap
structur
present
end
rna
convert
left
panel
figur
also
observ
methyl
induc
weakli
stimul
presenc
influenc
presenc
inde
convert
substrat
product
wherea
presenc
substrat
convert
judg
autoradiographi
analysi
alon
show
mtase
activ
three
protein
present
substrat
fulli
methyl
cap
judg
comparison
product
gener
bifunct
domain
dengu
viru
protein
dv
use
posit
control
right
panel
figur
show
incub
rna
alon
result
structur
true
combin
test
contrast
cap
structur
occur
upon
incub
also
three
protein
use
togeth
therefor
conclud
cap
rna
correspond
first
nucleotid
sarscov
genom
repres
bona
fide
substrat
follow
rna
cap
mtase
activ
sarscov
moreov
tlc
analysi
allow
us
demonstr
inde
specif
methyl
rna
cap
structur
methyl
cap
rna
first
nucleotid
cap
also
observ
use
short
substrat
could
methyl
suggest
must
preced
conclud
exhibit
activ
absenc
wherea
latter
absolut
requir
cap
structur
previous
shown
interact
modestli
stimul
cap
activ
figur
increas
activ
broad
optimum
around
molar
excess
order
directli
monitor
order
sarscov
rnacap
methyl
perform
timecours
experi
use
substrat
conjunct
result
shown
figur
indic
methyl
substrat
inde
start
subsequ
structur
convert
ome
structur
ome
structur
never
observ
assay
even
use
larger
amount
data
shown
agreement
data
present
figur
show
substrat
methyl
thu
sarscov
cap
structur
prerequisit
recognit
pair
convert
structur
recent
identif
ctermin
domain
reveal
replicas
subunit
multifunct
protein
sinc
also
carri
exoribonucleas
activ
embed
ntermin
domain
interplay
two
function
analyz
use
mutagenesi
experi
mutat
conserv
residu
mtase
exoribonucleas
domain
evalu
possibl
interplay
longrang
regul
activ
conserv
residu
presum
involv
adometbind
mutat
alanin
exoribonucleas
domain
replac
conserv
residu
exonucleas
motif
ii
iii
de
ad
nucleas
superfamili
histag
mutant
protein
could
express
except
mutant
bare
solubl
figur
show
migrat
molecular
mass
similar
wt
upon
sdspage
next
analyz
activ
use
adomet
methyl
donor
result
show
point
mutat
complet
abolish
activ
agreement
hypothesi
mtase
domain
locat
ctermin
half
protein
conserv
residu
import
function
contrast
mutat
exonucleas
domain
significantli
interfer
mtase
activ
except
case
motif
idoubl
mutant
display
attenu
activ
observ
agreement
fact
ntermin
truncat
amino
acid
exoribonucleas
domain
abolish
activ
yeast
transcomplement
assay
thu
alter
nterminu
exoribonucleas
domain
may
still
interfer
mtase
activ
certain
extent
order
ascertain
support
activ
protein
engin
character
set
point
mutat
mutat
conserv
residu
form
canon
catalyt
tetrad
mrna
cap
put
catalyt
residu
sarscov
identifi
use
sequenc
align
homolog
fcov
famili
member
three
four
alanin
point
mutant
could
express
effici
wt
allow
purif
homogen
use
singlestep
affin
chromatographi
see
materi
method
still
smaller
amount
fourth
mutant
could
also
produc
purifi
obtain
suffici
solubl
protein
perform
mtase
assay
although
protein
yield
puriti
lower
mutant
figur
mutant
protein
activ
test
compar
wt
control
pair
activ
inde
complet
abolish
singl
mutat
put
catalyt
tetrad
residu
result
demonstr
although
stimul
activ
yet
unknown
mechan
catalyt
activ
resid
viral
mtase
exhibit
mani
origin
featur
rel
host
cell
mtase
counterpart
increasingli
explor
put
target
develop
antivir
order
set
sensit
inhibit
test
determin
precis
condit
measur
optimum
mtase
activ
use
respect
substrat
see
text
thu
defin
follow
standard
assay
condit
activ
measur
presenc
mm
trishcl
ph
mm
dtt
assay
buffer
use
togeth
mm
figur
illustr
stimul
activ
dosedepend
manner
use
molar
excess
correspond
maxim
stimul
could
achiev
inhibit
test
two
adomet
analog
document
mrna
cap
mtase
inhibit
properti
adohci
sadenosyllhomocystein
coproduct
methyl
transfer
sinefungin
also
use
compound
known
target
adometdepend
mtase
siba
mta
base
adenosin
guanosinecontain
structur
adenosin
adometanalog
test
well
gtp
gtp
capanalog
ribavirin
triphosph
well
eicartriphosph
gpppa
final
includ
two
inhibitor
flaviviru
mrna
cap
mtase
activit
aurintricarboxyl
acid
ata
expect
bind
mtase
activ
site
substitut
adamantan
compound
supposedli
bind
adometbind
site
interestingli
ata
shown
recent
inhibit
sarscov
replic
unknown
mechan
action
first
incub
candid
inhibitor
presenc
adomet
activ
determin
quantif
methyl
transfer
rna
substrat
respect
shown
figur
test
molecul
bare
inhibit
sarscov
mtase
cap
analog
gpppa
show
limit
inhibit
capac
sarscov
mtase
contrast
observ
adohci
sinefungin
ata
effici
inhibit
enzym
valu
adohci
activ
respect
figur
tenfold
higher
ki
valu
report
vv
respect
sinefungin
potent
inhibitor
vv
report
valu
nm
respect
show
potent
inhibit
profil
valu
nm
nm
respect
figur
valu
similar
valu
report
inhibit
activ
dv
nm
nm
obtain
valu
ata
sarscov
respect
figur
result
demonstr
sensit
assay
avail
discov
character
inhibitor
sarscov
render
low
valu
known
adometdepend
mtase
inhibitor
like
adohci
sinefungin
moreov
shown
mtase
two
put
target
ata
shown
inhibit
sarscov
replic
infect
cell
protein
previous
propos
play
role
viral
rna
synthesi
replicas
polyprotein
process
basi
analysi
mhv
mutant
work
propos
new
function
regul
enzym
involv
methyl
cap
structur
observ
seem
directli
relat
phenotyp
previous
describ
mutant
nevertheless
rna
cap
methyl
defect
limit
rna
stabil
may
therefor
contribut
decreas
viral
rna
synthesi
observ
mhv
mutant
show
catalyt
inert
methyl
reaction
figur
form
complex
figur
interestingli
wherea
least
molar
excess
requir
maxim
stimul
figur
quantif
protein
band
purifi
complex
indic
maximum
ratio
figur
assum
condit
maxim
stimul
nearli
molecul
associ
one
two
molecul
consid
reaction
mixtur
stimul
contain
nm
around
nm
figur
dissoci
constant
complex
roughli
estim
order
nm
complex
nm
complex
agreement
kd
nm
determin
plasmon
surfac
reson
analysi
lecin
p
person
commun
could
mechan
activ
may
increas
stabil
stabil
rna
bind
groov
contribut
rna
substrat
bind
andor
alloster
regul
substrat
affin
activ
similar
activ
mtase
involv
cap
pathway
previous
report
vv
cap
enzym
catalyt
effici
domain
vv
protein
stimul
addit
equimolar
concentr
small
vv
protein
contain
catalyt
residu
activ
achiev
increas
substrat
cosubstr
affin
well
turn
number
time
vv
exert
stabil
effect
vv
determin
crystal
structur
protein
complex
vv
reveal
vv
protein
structur
homolog
cap
reoviru
truncat
adomet
bind
domain
sarscov
crystal
structur
reveal
similar
mtase
fold
protein
protein
data
bank
pdb
activ
effect
might
also
exert
differ
level
via
alloster
activ
increas
substrat
affin
andor
turn
number
andor
stabil
presenc
two
zn
finger
major
structur
featur
like
relat
biolog
function
sinc
zn
finger
typic
function
interact
modul
bind
protein
nucleic
acid
small
molecul
interestingli
sever
mtase
previous
shown
regul
specif
interact
zn
finger
domain
sinc
first
zn
finger
lie
posit
charg
surfac
patch
might
involv
low
affin
interact
singl
doublestrand
rna
dna
affin
rna
appear
weak
explain
direct
role
rna
recruit
expect
sarscov
contain
specif
bind
site
structur
follow
small
stretch
nucleotid
predict
fcov
enzymat
assay
format
complex
might
provid
longer
substratebind
site
way
enhanc
affin
rna
substrat
nevertheless
given
fact
full
activ
effect
also
seen
short
substrat
contain
cap
nucleotid
use
surmis
extens
rna
bind
site
minor
import
work
need
order
understand
molecular
basi
activ
indic
cov
genom
rna
subgenom
rna
carri
structur
see
introduct
three
four
put
capform
enzym
function
requir
produc
structur
identifi
sarscov
cov
cap
structur
methyl
seem
follow
classic
sequenc
preced
modular
structur
two
separ
singledomain
enzym
correspond
scenario
metazoan
plant
contrast
dsrna
reovirus
one
multidomain
protein
contain
two
mtase
domain
flavivirus
negativestrand
rna
rna
vesiculovirus
mtase
activit
resid
singl
domain
larger
protein
use
singl
activ
site
characterist
featur
cov
mtase
recogn
nonmethyl
rna
cap
exclus
recogn
rna
cap
exclus
contrast
bifunct
mtase
recogn
nonmethyl
methyl
cap
structur
equal
affin
interestingli
flavivir
activ
regul
specif
viral
rna
secondari
structur
activ
seem
requir
particular
termin
dinucleotid
ag
sinc
sarscov
activ
complement
defect
yeast
suggest
specif
sequenc
andor
rna
structur
requir
activ
confirm
vitro
assay
observ
use
small
rna
substrat
correspond
natur
sequenc
present
end
cov
mrna
nevertheless
cov
cap
machineri
like
act
specif
viral
mrna
substrat
present
common
leader
sequenc
nucleotid
long
case
sarscov
mechan
achiev
select
may
depend
gtase
reaction
fine
regul
cap
enzym
proteinprotein
interact
within
replic
transcript
complex
regul
activ
small
protein
clearli
origin
featur
cov
mrna
cap
methyl
viral
encod
rna
cap
activ
identifi
variou
viru
famili
dsdna
poxvirus
dsrna
reovirus
rna
virus
vesicular
stomat
viru
rna
virus
like
flavivirus
mani
includ
coronavirus
shown
mutat
abolish
activ
clear
detriment
effect
replic
wherea
knockout
exert
moder
effect
observ
suggest
compound
specif
inhibit
cap
mtase
could
potent
antivir
agent
although
viral
mtase
inhibitor
also
report
inhibit
mammalian
mtase
sinefungin
adomet
analog
might
higher
specif
toward
viral
mtase
accordingli
shown
sinefungin
inhibit
fungal
mrna
cap
time
potenc
human
isoform
report
assay
use
substrat
constitut
sensit
screen
test
identif
character
inhibitor
activ
respect
sarscov
confirm
obtain
low
valu
known
adometdepend
mtase
inhibitor
adohci
sinefungin
furthermor
found
ata
compound
previous
report
put
blocker
catalyt
site
flavivirus
sarscov
replic
infect
cell
inhibit
sarscov
mtase
activ
valu
respect
thu
propos
two
sarscov
target
ata
lead
least
contribut
inhibit
sarscov
replic
conclus
result
identifi
character
main
viral
protein
player
sarscov
mrna
cap
methyl
specif
mechanist
origin
remain
unparallel
thu
far
open
new
avenu
investig
viral
rna
cap
field
increasingli
permeabl
drug
design
project
adomet
cap
analog
gpppa
purchas
new
england
biolab
compound
test
mtase
inhibitor
purchas
follow
provid
sigmaaldrich
adohci
adenosinehomocystein
gtp
siba
sinefungin
adenosylornithin
ribavirin
mta
cabomoyl
ata
aurintricarboxyl
acid
trilink
biotechnolog
ribavirintriphosph
ribavirin
eicar
triphosph
kind
gift
p
herdewijn
leuven
belgium
dissolv
dmso
previous
describ
ata
dissolv
naoh
describ
concentr
set
mm
compound
store
radioact
reagent
purchas
perkin
elmer
sarscov
sequenc
amplifi
rtpcr
genom
sarscov
access
number
previous
describ
gene
encod
residu
replicas
clone
use
gateway
technolog
invitrogen
express
vector
produc
recombin
protein
carri
ntermin
gene
also
clone
vector
impact
kit
new
england
biolab
gener
plasmid
allow
express
protein
fuse
inteinchitin
bind
domain
sarscov
complex
produc
e
coli
bipromotor
express
plasmid
kindli
provid
bruno
coutard
afmb
franc
backbon
sar
cov
express
tet
promot
encod
protein
fusion
ntermin
strep
tag
wherea
express
promot
encod
protein
fusion
ntermin
hexahistidin
tag
singl
point
mutant
mutant
number
start
begin
sequenc
mutant
mutant
number
start
begin
sequenc
gener
pcr
use
quickchang
mutagenesi
kit
stratagen
accord
manufactur
instruct
e
coli
cell
avidi
sa
franc
contain
plyss
plasmid
novagen
transform
variou
express
vector
grown
medium
contain
ampicillin
chloramphenicol
protein
express
induc
addit
iptg
final
concentr
nm
valu
cultur
reach
express
perform
h
wherea
bacteria
incub
h
bacteri
cell
pellet
frozen
resuspend
lysi
buffer
mm
hepe
ph
mm
nacl
mm
mm
supplement
mm
pmsf
mm
imidazol
dnase
triton
sonic
clarif
protein
purifi
two
step
chromatographi
except
mutant
purifi
onestep
imac
hispurtm
cobalt
resin
thermo
scientif
concentr
centrifug
filter
unit
millipor
twostep
purif
protein
start
imac
hispurtm
cobalt
resin
thermo
scientif
elut
lysi
buffer
supplement
mm
imidazol
protein
fraction
load
hiload
superdex
gel
filtrat
column
ge
healthcar
elut
mm
hepe
ph
mm
nacl
protein
fraction
concentr
around
mgml
store
presenc
glycerol
protein
express
fusion
inteinchitin
bind
domain
purifi
chitin
column
use
impact
kit
new
england
biolab
bacteri
lysat
load
onto
column
wash
mm
hepe
ph
nacl
triton
column
incub
mm
hepe
ph
mm
nacl
mm
dtt
hour
order
induc
intein
cleavag
next
protein
elut
mm
hepe
ph
nacl
buffer
subsequ
purifi
hiload
superdex
gel
filtrat
column
ge
healthcar
describ
ident
purifi
protein
confirm
malditof
trypsin
digest
sarscov
coexpress
perform
e
coli
strain
avidi
sa
franc
transform
plyss
plasmid
novagen
cultur
grown
reach
express
induc
ad
iptg
anhydrotetracyclin
cell
incub
h
bacteri
pellet
treat
given
solubl
protein
fraction
incub
streptactin
sepharos
iba
biotagnolog
wash
bound
protein
elut
mm
ddesthiobiotin
bind
buffer
analys
purifi
protein
complex
sdspage
intens
coomassiestain
band
quantifi
use
imagej
short
cap
rna
synthes
vitro
use
bacteriophag
dna
primas
purifi
highperform
liquid
chromatographi
hplc
previous
describ
rna
substrat
correspond
nucleotid
sarscov
genom
prepar
follow
utr
sarscov
genom
amplifi
pcr
use
primer
cgggatcccagtaatacgactcactattatattaggtttttacctaccc
ggaattccttacctttcggtcacac
clone
fermenta
plasmid
bamhiecori
restrictionlig
procedur
class
ii
promot
use
underlin
primer
second
nucleotid
genom
u
substitut
g
transcript
matrix
amplifi
pcr
primer
cgggatcccagtaatacgactcactattagattaggtttttacctaccc
cttacctttcggtcacac
purifi
agaros
gel
use
qiaquick
gel
extract
kit
qiagen
rna
substrat
synthes
vitro
transcript
use
megashortscript
rna
polymeras
kit
ambion
dnase
treatment
ambion
purif
rneasi
mini
kit
qiagen
rna
incub
h
vv
cap
enzym
scriptcap
cap
kit
epicentr
biotecholog
reaction
volum
either
absenc
presenc
adomet
accord
instruct
manufactur
gtp
perkinelm
boston
unit
inorgan
pyrophosphatas
use
radiolabel
cap
rna
purifi
rneasi
mini
kit
qiagen
mtase
activ
assay
perform
mm
trishcl
ph
mm
dtt
mm
adomet
cand
adomet
ge
healthcar
standard
assay
ad
final
concentr
nm
nm
respect
final
concentr
use
assay
chosen
stay
linear
phase
product
format
h
incub
use
substrat
molar
excess
chosen
achiev
maxim
stimul
activ
condit
methyl
reaction
convert
similar
amount
substrat
h
reaction
sign
protein
inactiv
found
appar
end
linear
phase
reaction
mixtur
incub
stop
indic
time
dilut
reaction
mixtur
icecold
adohci
sampl
kept
ice
transfer
glassfib
filtermat
deae
filtermat
wallac
filtermat
harvest
packard
instrument
filtermat
wash
twice
ammonium
format
ph
twice
water
ethanol
dri
transfer
sampl
bag
betapl
scint
wallac
scintil
fluid
ad
methyl
rna
substrat
measur
count
per
minut
cpm
use
wallac
microbeta
trilux
liquid
scintil
counter
inhibit
assay
set
reaction
describ
presenc
inhibitor
candid
enzym
rna
substrat
mix
inhibitor
addit
adomet
start
reaction
final
concentr
dmso
reaction
mixtur
control
reaction
perform
presenc
dmso
alter
mtase
activ
reaction
mixtur
incub
h
analyz
filter
bind
assay
describ
inhibitor
concentr
activ
valu
adohci
sinefungin
ata
determin
use
kaleidagraph
data
adjust
logist
doserespons
function
activ
b
b
correspond
slope
factor
correspond
inhibitor
concentr
mtase
activ
assay
perform
mm
trishcl
ph
mm
dtt
mm
adomet
cap
rna
reaction
stop
differ
reaction
time
incub
sampl
min
sampl
treat
overnight
proteinas
k
invitrogen
proteinas
k
inactiv
addit
mm
pmsf
rna
subsequ
digest
h
nucleas
usbiolog
radiolabel
cap
analog
standard
produc
direct
digest
substrat
lead
gpppa
digest
methyl
use
vv
scriptcap
kit
epicentr
biotechnolog
lead
ome
ome
digest
product
separ
polyethyleneimin
cellulos
thinlay
chromatographi
tlc
plate
macherey
nagel
use
mobil
phase
dri
tlc
plate
cap
releas
nucleas
visual
use
phosphorimag
fluoresc
imag
analyz
fuji
